These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15970435)

  • 1. Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations.
    Cheng YH; Dyer AM; Jabbal-Gill I; Hinchcliffe M; Nankervis R; Smith A; Watts P
    Eur J Pharm Sci; 2005 Sep; 26(1):9-15. PubMed ID: 15970435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence between ready-to-use recombinant human growth hormone (rhGH) in liquid formulation and rhGH for reconstitution.
    Jacobsen LV; Rolan P; Christensen MS; Knudsen KM; Rasmussen MH
    Growth Horm IGF Res; 2000 Apr; 10(2):93-8. PubMed ID: 10931747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.
    Luthringer R; Djupesland PG; Sheldrake CD; Flint A; Boeijinga P; Danjou P; Demazières A; Hewson G
    J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats.
    Bosquillon C; Préat V; Vanbever R
    J Control Release; 2004 Apr; 96(2):233-44. PubMed ID: 15081215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel sustained release formulation of recombinant human growth hormone using sodium hyaluronate microparticles.
    Kim SJ; Hahn SK; Kim MJ; Kim DH; Lee YP
    J Control Release; 2005 May; 104(2):323-35. PubMed ID: 15907583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence studies for three formulations of a recombinant human growth hormone: challenges and lessons learned.
    Dao L; Jacobs J; Kuebler P; Bakker B; Lippe B
    Growth Horm IGF Res; 2010 Oct; 20(5):367-71. PubMed ID: 20708421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Human Growth Hormone (hGH) Induces IGF-1 Levels Comparable With Subcutaneous Injection With Lower Systemic Exposure to hGH in Healthy Volunteers.
    Lewis AL; Jordan F; Patel T; Jeffery K; King G; Savage M; Shalet S; Illum L
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4364-71. PubMed ID: 26425883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
    Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
    Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.
    Dyer AM; Hinchcliffe M; Watts P; Castile J; Jabbal-Gill I; Nankervis R; Smith A; Illum L
    Pharm Res; 2002 Jul; 19(7):998-1008. PubMed ID: 12180553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological efficiency and bioavailability of human growth hormone delivered using injectable, ionic, thermosensitive poly(organophosphazene)-polyethylenimine conjugate hydrogels.
    Seo BB; Park MR; Chun C; Lee JY; Song SC
    Biomaterials; 2011 Nov; 32(32):8271-80. PubMed ID: 21839508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of nicotine lyophilised nasal insert in sheep.
    McInnes FJ; Thapa P; Baillie AJ; Welling PG; Watson DG; Gibson I; Nolan A; Stevens HN
    Int J Pharm; 2005 Nov; 304(1-2):72-82. PubMed ID: 16183221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep.
    Hinchcliffe M; Jabbal-Gill I; Smith A
    J Pharm Pharmacol; 2005 Jun; 57(6):681-7. PubMed ID: 15969922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary investigation of the nasal delivery of liposomal leuprorelin acetate for contraception in rats.
    Shahiwala A; Misra A
    J Pharm Pharmacol; 2006 Jan; 58(1):19-26. PubMed ID: 16393460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system.
    Leitner VM; Guggi D; Krauland AH; Bernkop-Schnürch A
    J Control Release; 2004 Nov; 100(1):87-95. PubMed ID: 15491813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo characterization of sustained-release formulations of human growth hormone.
    Lee HJ; Riley G; Johnson O; Cleland JL; Kim N; Charnis M; Bailey L; Duenas E; Shahzamani A; Marian M; Jones AJ; Putney SD
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1431-9. PubMed ID: 9190880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies.
    Aksungur P; Sungur A; Unal S; Iskit AB; Squier CA; Senel S
    J Control Release; 2004 Aug; 98(2):269-79. PubMed ID: 15262418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of recombinant human growth hormone administered by cool.click 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle.
    Brearley C; Priestley A; Leighton-Scott J; Christen M
    BMC Clin Pharmacol; 2007 Oct; 7():10. PubMed ID: 17922895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
    Krauland AH; Guggi D; Bernkop-Schnürch A
    Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of a new formulation of recombinant human growth hormone administered by ZomaJet 2 Vision, a new needle-free device, compared to subcutaneous administration using a conventional syringe.
    Agersø H; Møller-Pedersen J; Cappi S; Thomann P; Jesussek B; Senderovitz T
    J Clin Pharmacol; 2002 Nov; 42(11):1262-8. PubMed ID: 12412826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.